Can the NHS Prescribe Mounjaro for Weight Loss?

What the NHS threshold for Mounjaro actually is right now

NICE recommended tirzepatide for NHS use in December 2024 (updated September 2025), but the recommendation came with a phased rollout rather than open access. The current position, per NICE technology appraisal TA1026, is that NHS prescribing began in June 2025 for adults with a BMI of 40 or above who also have four or more of five specific weight-related conditions: type 2 diabetes, high blood pressure, dyslipidaemia, obstructive sleep apnoea, or established cardiovascular disease. That is a high bar.

From around June 2026, a second cohort opened: BMI 35–39.9 with four or more of the same conditions. A further expansion is expected around March 2027 for adults with a BMI of 40 or above who have three of the five conditions. Lower BMI thresholds apply for South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds throughout, as detailed on the NHS Mounjaro entitlement page.

Meeting the criteria does not guarantee access. Every NHS patient must also take part in wrap-around diet and physical activity support, and capacity within local services varies. The NHS thresholds exist partly because of supply constraints and partly to prioritise people with the greatest clinical need. If your BMI or comorbidity count falls short of the current cohort, the NHS route is not open to you yet, regardless of how suitable you might otherwise be.

Whether your GP can prescribe it, and why the answer is complicated

Since April 2026, GP practices can prescribe Mounjaro under the new GP contract QOF arrangements. In theory, that means your own doctor could be the prescriber rather than a hospital specialist. In practice, participation is voluntary, so whether your practice has signed up depends entirely on the local integrated care board and the individual surgery. Some GPs are already prescribing; others have not opted in at all.

There is also a clinical-criteria layer on top of the GP route: the same NHS cohort thresholds apply. A GP prescribing Mounjaro on the NHS is still prescribing within the NICE TA1026 framework, so if you fall into Cohort 2 or later, you need a GP whose practice participates and whose local ICB has activated that cohort. The page on whether a GP can prescribe Mounjaro covers the practical steps for finding out where your practice stands. If your surgery is not participating, asking your GP to write a private prescription is a separate conversation, and not all GPs will do so.

If you are wondering whether your specific doctor can prescribe Mounjaro for you, it is worth reading up on the distinction between NHS and private prescribing before you book an appointment, as the answer often depends on your practice's individual arrangements rather than a simple yes or no.

Understanding who is legally authorised to prescribe Mounjaro in the UK is worth a quick read before you book any appointment, whether NHS or private.

What happens if you do not meet the NHS criteria today

For people who are clinically suitable under the Mounjaro licence (adults with a BMI of 30 or above, or 27 or above with a weight-related condition) but who sit outside the current NHS cohorts, the licensed route is a private prescription from a regulated pharmacy. This is not a workaround, it is the same medicine, prescribed by a qualified clinician, dispensed through a GPhC-registered UK pharmacy.

The cost is real and worth thinking about honestly. Eli Lilly raised Mounjaro's UK list price significantly from September 2025, the highest dose pen rose to around £330 per month at list price, and private providers typically charge in the range of £149–£375 per month depending on dose and service. A transparent pricing breakdown is something to ask any provider about upfront; the context behind the 2025 price increase is worth reading before you compare quotes.

At nume, a single transparent price covers the consultation, the prescription, the medicine itself and tracked next-working-day delivery. There are no hidden fees. If you want to explore this route, the treatment options page is the place to start your free consultation. Clinical suitability is assessed by a GPhC-registered prescriber, not by an automated screening tool.

The question most people are actually asking

Underneath the NHS vs private framing, most people want to know whether they can get Mounjaro without a long wait and without falling into a gap in NHS eligibility. The honest answer is: if your BMI and medical history meet the current NHS cohort criteria, it is worth speaking to your GP surgery first, because NHS-funded treatment has obvious advantages. If you are outside those cohorts, or your practice has not opted in, private prescription through a registered pharmacy is the only legal route available right now.

According to NHS England's guidance on weight-management injections, the NHS rollout will continue expanding over the next couple of years, but the pace depends on supply and local commissioning decisions. Keeping an eye on whether your local practice joins the scheme is sensible. For anyone deciding between routes today, the key question is not which route sounds best, it is which route you actually qualify for. A prescriber can help you work that out.

If you would like to understand whether the private route makes sense for your situation, you can start a free consultation with our prescribing team, who review every case personally on the same day.